SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: IRWIN JAMES FRANKEL who wrote (4580)8/30/2001 11:16:04 PM
From: Jibacoa  Read Replies (1) | Respond to of 52153
 
<<But of the twins ABGX usually moves first.>>

That may be so.<g> But in the last 2 months (since July ) some of the "low priced" ones like BTRN and more so lately CRIS have been outperforming the "twins"

siliconinvestor.com

Of course, I must point out that the comparison with CRIS may not be a valid one since in July was that the "merger" took place.<g>

RAGL

Bernard



To: IRWIN JAMES FRANKEL who wrote (4580)8/31/2001 9:05:59 AM
From: schzammm  Read Replies (1) | Respond to of 52153
 
Medx/abgx twins-an alternative play

I have been buying the medx 4.50% 2006 convertible bonds on any weakness in medx. The bonds have been selling at a discount on the drop in the stock and pay 5+% on the current yield. When/if the stock hits 29 the bonds will go $ for $ with the stock. Nice feature is the bonds can not be called until 2004. As always do you own DD.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News